• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER (CE); CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL G4 STEERABLE GUIDING CATHETER (CE); CATHETER, STEERABLE Back to Search Results
Model Number SGC0701
Device Problem Material Split, Cut or Torn (4008)
Patient Problems Hemorrhage/Bleeding (1888); Hypoxia (1918); Perforation (2001); Perforation of Vessels (2135)
Event Date 05/05/2023
Event Type  Injury  
Event Description
This is filed to report soft tip damage, atrial perforation, femoral vein perforation and hypoxia requiring intervention.It was reported that a mitraclip procedure was performed to treat mitral regurgitation (mr) grade 4.An xtw clip (21214r1117) was positioned on the valve.However, it was noted that the clip delivery system (cds) was curved more than 90 degrees, as the physician used an excessive amount of m knob.During establishment of final arm angle (efaa) the clip would reopen from 10 degrees to 70 degrees.The device was pulled back into the left atrium and while retracting the clip into the steerable guide catheter (sgc, 21103r1051), the physician pulled the clip hard.As a result, the clip detached from the cds but remained attached by the lock lines.The clip could not re-enter the sgc so the entire system was pulled into the right atrium and removed from the body intact.During this removal, sgc soft tip damage occurred from the clip gripper.Also, femoral vein bleeding was observed after the system was removed, and the patient became hypoxic from a right to left shunt formed from an atrial septal defect (asd).The vessel perforation was repaired with a surgical suture.Heparin was reversed and the patient was watched to make sure the bleeding stopped.This issue reportedly caused a clinically significant delay in the procedure.A femstop was placed on the right groin and the left groin was prepped and a new sgc was advanced via left femoral vein.A replacement mitraclip was successfully implanted, reducing mr to grade 1.After the procedure, an occluder was placed to treat the shunt from the asd.No additional information was provided.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The additional mitraclip referenced in b5 will be filed under a separate medwatch report number.
 
Manufacturer Narrative
All available information was investigated, and the reported material split, cut, or torn (soft tip) was confirmed via returned device analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the reported torn sgc soft tip was due to procedural circumstances (i.E., forcible retraction of clip through the sgc).The reported hemorrhage and perforation of vessels associated with the bleeding at femoral vein appears to be due to the inverted clip being pulled out as the inverted clip arms would likely damage the blood vessel.The reported hypoxia was due to the asd.A cause of the reported perforation (asd) could not be determined.The reported patient effects of perforation and hemorrhage, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention, hospitalization, surgical intervention, and delay to treatment/ therapy were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER (CE)
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17004614
MDR Text Key315995389
Report Number2135147-2023-02320
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648231025
UDI-Public08717648231025
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/02/2023
Device Model NumberSGC0701
Device Catalogue NumberSGC0701
Device Lot Number21103R1051
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/03/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MITRACLIP XTW
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age84 YR
Patient SexMale
-
-